InvestorsHub Logo
Followers 102
Posts 13168
Boards Moderated 0
Alias Born 06/29/2005

Re: goodibag post# 20456

Tuesday, 12/12/2017 4:54:36 PM

Tuesday, December 12, 2017 4:54:36 PM

Post# of 37542
I like this part.

"Additionally, Omni Health is in the final stages of development of non-prescription CBD analgesic creams and ointments with fast absorption properties which we are able to rapidly deploy to the market.

Simultaneous to the FDA application for this new drug, the Company will commence by manufacturing OTC analgesic creams and ointments containing CBD with rapid absorption and optimal bioavailability profiles. Given the potency of these analgesics, they will be marketed and distributed exclusively to doctors’ offices, clinics, and hospitals to ensure appropriate patient support and product usage. As per the current schedule, it’s anticipated they this product will be introduced to the North American market during Q3 2018. Based on current market trends and competitor analysis, Omni Health projects generating a recurring annual revenue exceeding $7 Million."